Brief: Genor Biopharma Holdings Posts H1 Net Income Attributable RMB -125.7 Million
28/08/2024 15:52
Aug 28 (Reuters) - Genor Biopharma Holdings H1 revenue RMB 14.5 million. * H1 net income attributable RMB -125.7 million
Recent news on Edding Genor group
See all newsBrief: Edding Genor Says CEO Initiates Plan To Purchase Additional Shares In Open Market
Brief: Edding Genor Posts Net Profit Increased To Rmb399.3 Million In 2025
Brief: Genor Biopharma Says NMPA Granted New Drug Application Approval For Lerociclib (Gb491)
Brief: Genor Biopharma, Its Unit & Edding Group Entered Into Merger Agreement
Brief: Genor Biopharma Says Guo Feng Tendered His Resignation As Chairman